Abstract
Natural-killer (NK) cells are lymphocytes that do not express the CD3 T-cell receptor but do express the CD16 (FcγRIII) and CD56 (isoform of NCAM) in humans or NK1.1 antigen in certain strains of mice. NK cells display spontaneous lytic activity but do not exhibit immunological memory. NK cells are important mediators of antiviral and antitumor immunity. Standard NK cytolysis assays measure the ability of NK cells to kill certain target cells (tumor cells, virally infected cells) in short-term (usually 4–6 h) cytolysis assays. This chapter details the use of the NK cell cytolysis assay using polyclonal populations of human or rodent NK cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Papamichail, M., Perez, S. A., Gritzapis, A. D., and Baxevanis, C. N. (2004) Natural killer lymphocytes: biology, development, and function. Cancer Immunol. Immunother. 53, 176–186.
Hamerman, J. A., Ogasawara, K., and Lanier, L. L. (2005) NK cells in innate immunity. Curr. Opin. Immunol. 17, 29–35.
Smyth, M. J., Cretney, E., Kelly, J. M., et al. (2005) Activation of NK cell cytotoxicity. Mol. Immunol. 42, 501–510.
Moretta, L. and Moretta, A. (2004) Unraveling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 23, 255–259.
Chiesa, S., Tomasello, E., Vivier, E., and Vely, F. (2005) Coordination of activating and inhibitory signals in natural killer cells. Mol. Immunol. 42, 477–484.
Cook, J. L., May, D. L., Wilson, B. A., et al. (1989) Role of tumor necrosis factoralpha in E1 A oncogene-induced susceptibility of neoplastic cells to lysis by natural killer cells and activated macrophages. J. Immunol. 142, 4527–4534.
Routes, J. M. and Cook, J. L. (1995) E1A gene expression induces susceptibility to killing by NK cells following immortalization but not adenovirus-infection of human cells. Virology 210, 421–428.
Cook, J. L., Potter, T. A., Bellgrau, D., and Routes, B. A. (1996) E1A oncogene expression in target cells induces cytolytic susceptibility at a post-recognition stage in the interaction with killer lymphocytes. Oncogene 12, 833–842.
Cook, J. L., Routes, B. A., Leu, C. Y., Walker, T. A., and Colvin, K. L. (1999) E1 A oncogene-induced cellular sensitization to immune-mediated apoptosis is independent of p53 and resistant to blockade by E1B 19 kDa protein. Exp. Cell. Res. 252, 199–210.
Routes, J. M., Ryan, S., Clase, A., et al. (2000) Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL). J. Immunol. 165, 4522–4527.
Duerksen-Hughes, P., Wold, W. S. M., and Gooding, L. R. (1989) Adenovirus E1 A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143, 4193–4200.
Cook, J. L. and Lewis, A. M., Jr. (1987) Immunological surveillance against DNA virus-transformed cells: correlations between natural killer cell cytolytic competence and tumor susceptibility of athymic rodents. J. Virol. 61, 2155–2161.
Cook, J. L., Krantz, C. K., and Routes, B. A. (1996) Role of p300-family proteins in E1 A oncogene induction of cytolytic susceptibility and tumor cell rejection. Proc. Natl. Acad. Sci. USA 93, 13,985–13,990.
Routes, J. M., Ryan, S., Steinke, J., and Cook, J. L. (2000) Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1 A proteins influence primary tumor development. Virology 277, 48–57.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc, Totowa, NJ
About this protocol
Cite this protocol
Routes, J.M. (2007). Measurement of Natural-Killer Cell Lytic Activity of Adenovirus-Infected or Adenovirus-Transformed Cells. In: Wold, W.S.M., Tollefson, A.E. (eds) Adenovirus Methods and Protocols. Methods in Molecular Medicine™, vol 131. Humana Press. https://doi.org/10.1007/978-1-59745-277-9_15
Download citation
DOI: https://doi.org/10.1007/978-1-59745-277-9_15
Publisher Name: Humana Press
Print ISBN: 978-1-58829-901-7
Online ISBN: 978-1-59745-277-9
eBook Packages: Springer Protocols